ONCOGENE AS

Signals

1 flags

• ◆ Nylig endring 2026-04-28 Aksjekapital registrert 2026-04-28.

ONCOGENE AS is registered as a limited company in Lillestrøm, Akershus with organisation number 825818642. The business is classified under technical testing and analysis (NACE 71.200). The company was incorporated in 2020. Registered share capital is NOK 32,000, divided into 319 shares. The company's stated purpose is: “Tilby genetiske analyser for privatpersoner, forskning og annen næringsvirksomhet, samt bioinformatikk analyse av alle slag for presisjonsmedisin og personalisert terapi, og annet som naturlig faller sammen med dette.”. The most recent filed accounts, for the 2024 financial year, show NOK 644,000 in revenue and NOK 201,000 in operating profit.

Key figures · 2024

Revenue

NOK 644,000

Operating profit

NOK 201,000

Equity

NOK 1.1m

Est. value

NOK 1.2m

Financial health · 2024

Liquidity

0.43

Not satisfactory

Current assets ÷ current liabilities

Profitability

–

Not available

Return on total assets

Solidity

14.6%

Satisfactory

Equity as a share of total capital

Who owns ONCOGENE AS?

MODUS I AS

72.0%

ONCOGENE AS

NOK 644,000 rev. · NOK 201,000 profit

ONCOGENE AS has 6 registered shareholders:

• MODUS I AS 72.0%
• ECONTO AS 10.0%
• IDA CHRISTINE FILTENBORG HANSEN 5.0%
• TORE HELGE RISMYHR 5.0%
• MAKRI INVEST AS 5.0%
• BINITA DEBNATH 3.0%

All shareholders and roles →

Frequently asked questions about ONCOGENE AS

Who owns ONCOGENE AS?

MODUS I AS is the largest registered owner, with 72.0%.

What is the revenue of ONCOGENE AS?

ONCOGENE AS had revenue of NOK 644,000 in 2024.

Who is the general manager of ONCOGENE AS?

Morten Bjelke-Holtermann Duesund is registered as general manager of ONCOGENE AS.

Where is ONCOGENE AS based?

ONCOGENE AS has its business address in Kjeller.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.